These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14650833)

  • 1. Cell, gene and vaccine based strategies in kidney cancer.
    Gitlitz BJ; Figlin RA
    Cancer Treat Res; 2003; 116():183-98. PubMed ID: 14650833
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.
    Bellmunt J; Ribas A
    Eur Urol; 2009 Jun; 55(6):1342-3. PubMed ID: 19201525
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.
    Clark PE
    Eur Urol; 2009 Jun; 55(6):1343-4. PubMed ID: 19201523
    [No Abstract]   [Full Text] [Related]  

  • 4. New therapeutic developments in renal cell cancer.
    Prenen H; Gil T; Awada A
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):56-63. PubMed ID: 18752971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody therapy of kidney cancer.
    Oosterwijk E; Brouwers A; Boerman OC; Larson SM; Old LJ; Mulders P; Divgi CR
    Cancer Treat Res; 2003; 116():199-212. PubMed ID: 14650834
    [No Abstract]   [Full Text] [Related]  

  • 6. Improving the retroviral vector (RV) systems for immunotherapy of cancer.
    Grabarczyk P; Gryska K; Wysocki PJ; Izycki D; Mackiewicz A
    Adv Exp Med Biol; 2001; 495():389-92. PubMed ID: 11774599
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapeutic approaches for renal cancer.
    Pizza G; de Vinci C; Viza D
    Folia Biol (Praha); 2002; 48(5):167-81. PubMed ID: 12448765
    [No Abstract]   [Full Text] [Related]  

  • 8. Perspective: What next for treatment?
    Motzer RJ
    Nature; 2016 Sep; 537(7620):S111. PubMed ID: 27626781
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeted therapy: An elusive cancer target.
    Brown C
    Nature; 2016 Sep; 537(7620):S106-8. PubMed ID: 27626779
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials.
    Lenis AT; Donin NM; Johnson DC; Faiena I; Salmasi A; Drakaki A; Belldegrun A; Pantuck A; Chamie K
    J Urol; 2018 Jan; 199(1):43-52. PubMed ID: 28479237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes.
    Saliby RM; Labaki C; Jammihal TR; Xie W; Sun M; Shah V; Saad E; Kane MH; Kashima S; Sadak K; El Zarif T; Poduval D; Motzer RJ; Powles T; Rini BI; Albiges L; Pal SK; McGregor BA; McKay RR; Signoretti S; Van Allen EM; Shukla SA; Choueiri TK; Braun DA
    Cancer Cell; 2024 May; 42(5):732-735. PubMed ID: 38579722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal cell carcinoma associated proteins. Isolation, cloning and immunogenicity evaluation].
    Haferkamp A; Hohenfellner M; Hautmann R; Zöller M
    Urologe A; 2007 Sep; 46(9):1292-8. PubMed ID: 17628779
    [No Abstract]   [Full Text] [Related]  

  • 13. Active and passive immunotherapy: vaccines and antibodies.
    Oosterwijk E; Divgi C; Bander NH
    BJU Int; 2007 May; 99(5 Pt B):1301-4. PubMed ID: 17441928
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination immunotherapy in metastatic renal cell carcinoma. Are we leaving something back?
    Di Nunno V; Gatto L; Fragomeno B; Cubelli M; Nobili E; Romano I; Santoni M; Pisconti S; Montironi R; Massari F
    Future Oncol; 2018 Dec; 14(29):2997-2999. PubMed ID: 30411632
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy and prognostic factors.
    Fumagalli LA; Brivio F
    J Clin Oncol; 2006 Sep; 24(25):4218-9; author reply 4219-20. PubMed ID: 16943541
    [No Abstract]   [Full Text] [Related]  

  • 16. Current immunotherapeutic strategies in renal cell carcinoma.
    Amato RJ
    Surg Oncol Clin N Am; 2007 Oct; 16(4):975-86, xi-xii. PubMed ID: 18022554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular vaccine therapies for cancer.
    Mastrangelo MJ; Sato T; Lattime EC; Maguire HC; Berd D
    Cancer Treat Res; 1998; 94():35-50. PubMed ID: 9587681
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy for renal carcinoma: theoretical basis and current standard of care.
    Vasey PA
    Br J Clin Pharmacol; 2000 Dec; 50(6):521-9. PubMed ID: 11136291
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccines for melanoma and renal cell carcinoma.
    Kaufman HL
    Semin Oncol; 2012 Jun; 39(3):263-75. PubMed ID: 22595049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for renal cell cancer.
    Yang JC; Childs R
    J Clin Oncol; 2006 Dec; 24(35):5576-83. PubMed ID: 17158543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.